Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE® Technology

Corporate Breaking News

Home : Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE® Technology

Oct 06 2020	Halozyme Announces Expansion Of Collaboration And License Agreement With argenx For ENHANZE® Technology
SAN DIEGO, Oct. 6, 2020 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Halozyme and argenx are expanding their existing global collaboration and license agreement that was signed in February 2019. Under the newly announced expansion, argenx gained the...


Source:https://www.prnewswire.com:443/news-releases/halozyme-announces-expansion-of-collaboration-and-license-agreement-with-argenx-for-enhanze-technology-301146244.html

Related News
» The Lancet Gastroenterology and Hepatology publishes InDex Pharmaceuticals' results of the phase IIb study with cobitolimod » En un periodo de turbulencia social, Igor Rybakov lanza un programa social pre-escolar